Kurier Medyczny

Abstract

2/2020

Etanercept firmy Sandoz (Erelzi®), infliksymab firmy Sandoz (Zessly®) oraz adalimumab firmy Sandoz (Hyrimoz®) – 2019 Novel Coronavirus (SARS-CoV-2) i choroba wywołana przez koronawirusa (coronavirus disease, COVID-19)

Online publish date: 2020/05/11
View full text
Share
without publication fees
without publication fees
We recommend